Brief: Prokidney Corp - Topline Data Readout Of Surrogate Endpoint Expected Q2 2027
02/02/2026 21:23
Feb 2 (Reuters) - Prokidney Corp PROK.O: PROKIDNEY CORP - TOPLINE DATA READOUT OF SURROGATE ENDPOINT EXPECTED Q2 2027 - SEC FILING PROKIDNEY CORP - TOPLINE DATA READOUT OF SURROGATE ENDPOINT EXPECTED IN H2 2029 - SEC FILING PROKIDNEY CORP - UPDATES PHASE 3 STUDY ENROLLMENT TO 470 SUBJECTS - SEC FILING Further company coverage: PROK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prokidney
See all newsProkidney Corp reports results for the quarter ended September 30 - Earnings Summary
ProKidney Q3 loss widens on higher R&D costs
Brief: ProKidney Q3 Operating Income USD -53.758 Million
Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise